IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer
Masataka Amisaki(National Cancer Center Hospital East), Vinod P. Balachandran(Memorial Sloan Kettering Cancer Center), David Artis(Cornell University), Ivo C. Lorenz(Tri-Institutional Therapeutics Discovery Institute), Rebecca Yu(Memorial Sloan Kettering Cancer Center), Manuel Baca(Tri-Institutional Therapeutics Discovery Institute), Rui Gardner(Memorial Sloan Kettering Cancer Center), Adrienne Kaya Chandra(Memorial Sloan Kettering Cancer Center), Martina Milighetti(Memorial Sloan Kettering Cancer Center), Julia N. Zhao(Memorial Sloan Kettering Cancer Center), Alexei V. Tumanov(Engelhardt Institute of Molecular Biology), Mithat Gönen(Memorial Sloan Kettering Cancer Center), Ashley S. Doane, John A. Moral(Memorial Sloan Kettering Cancer Center), Kevin C. Soares(Memorial Sloan Kettering Cancer Center), Pablo Guasp(Memorial Sloan Kettering Cancer Center), Benjamin D. Greenbaum(Memorial Sloan Kettering Cancer Center), Emmanuel M. Bruno(Memorial Sloan Kettering Cancer Center), Luis A. Rojas(Institut de Seguretat Pública de Catalunya), Siqi Linsey Zhang(Memorial Sloan Kettering Cancer Center), Charlotte Reiche(Memorial Sloan Kettering Cancer Center), Akihiro Ohmoto(Japanese Foundation For Cancer Research), Abderezak Zebboudj(Memorial Sloan Kettering Cancer Center), George C. Payne(Memorial Sloan Kettering Cancer Center), Zachary Sethna(Memorial Sloan Kettering Cancer Center), Elisabeth K. Nyakatura(Tri-Institutional Therapeutics Discovery Institute), Stephen Martis(Memorial Sloan Kettering Cancer Center), Theresa Waters(Memorial Sloan Kettering Cancer Center), Abdul G. Khan(Tri-Institutional Therapeutics Discovery Institute), Erin Patterson(Memorial Sloan Kettering Cancer Center), Zagaa Odgerel(National Institutes of Health), C. K. Cheng(Memorial Sloan Kettering Cancer Center), Alexander Solovyov(Memorial Sloan Kettering Cancer Center), Taha Merghoub(Cornell University), Olivia Vergnolle(Tri-Institutional Therapeutics Discovery Institute), Hiroshi Yano(Cornell University)
Cited by 83
Related Papers
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k